Purchase Order 36C26222P0791
Award Date 3/10/22
Potential Completion Date 3/9/23
Potential Value $622K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Long Beach, CA 90815, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Diasorin Inc., a for-profit foreign-owned company, for the provision of chemiluminescence immunoassay supplies and services. The $329,964.00 contract is to support VA healthcare facilities in Long Beach, California. Diasorin, a major provider of diagnostic testing products and services to federal agencies including the VA, Department of Defense, and Department of...
- The Department of Veterans Affairs Veterans Health Administration awarded a $746,895.10 firm-fixed-price blanket purchase agreement call contract to Diasorin Inc. of Long Beach, California. The contract is for chemiluminescence immunoassay tests for bisphenol A and supports the VA's COVID-19 National Interest Action Code and programs under Veterans Integrated Service Network 22. Diasorin will provide the tests from its Long Beach location under the one-year contract running from March 10, 2021...
- Diasorin Inc. was awarded an indefinite-delivery, indefinite-quantity (IDIQ) delivery order against the Department of Veterans Affairs Veterans Health Administration (VHA) National Acquisition Center's Diagnostic Services Blanket Purchase Agreement (BPA) to provide DiASorin XL Analyzer cost per test services for $85,485. The order has a period of performance through September 30, 2022 and was awarded on October 5, 2021 without a set-aside designation. Under this delivery order, Diasorin Inc....
- The Department of Veterans Affairs Veterans Integrated Service Network 22 awarded a $2.27 million purchase order to Diasorin Inc. for immunoassay reagents on March 20, 2025, with a completion date of September 19, 2026. This firm-fixed-price contract with no set-aside designation will supply FDA-approved reagents and related consumables compatible with Diasorin's LIAISON XL chemiluminescence immunoassay analyzer systems serving five VA healthcare facilities across California and Arizona. The...
- Diasorin Inc. was awarded a $106,031.01 firm fixed price delivery order against an unspecified multiple award contract vehicle by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4. The contract calls for Diasorin to provide immunoassay testing supplies in support of the agency's medical programs. Performance will occur in Philadelphia, Pennsylvania with an estimated completion date of May 7, 2025. No set-aside provisions were applied to...
- The Department of Veterans Affairs, Veterans Integrated Service Network 17, awarded a delivery order valued at $58,249.06 to Diasorin Inc. for AMA DiaSorin Reagents under Ordering Period 3, with performance scheduled through July 14, 2027. This delivery order was issued without a set-aside designation and represents a firm fixed-price procurement of diagnostic reagents to support laboratory testing operations at VA facilities. Diasorin Inc., a Minnesota-based subsidiary of Italian-owned Diasorin...
- The Department of Veterans Affairs, Veterans Integrated Service Network 7, awarded a $229,166 firm fixed-price purchase order to Diasorin Inc. for the lease of a LIAISON XL analyzer, reagents, and preventative maintenance services. The award, issued December 1, 2021, with an ultimate completion date of November 30, 2026, represents a continuation of the VA's established relationship with Diasorin for advanced diagnostic laboratory equipment and supplies. Diasorin Inc., a Minnesota-based...
- Diasorin Inc. was awarded a $184,946 firm fixed price delivery order against an unspecified government-wide acquisition contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9. The contract calls for Diasorin to provide reagents and Liaison XL analyzers to support laboratory testing services. To be performed in Stillwater, Minnesota, the period of performance is from October 1, 2021 through September 30, 2022. No set-aside provisions...
- The Department of Veterans Affairs (VA) awarded a $146,011.47 firm-fixed-price purchase order to Diasorin Inc., a foreign-owned for-profit medical diagnostics company, for the maintenance and consumables support of LIAISON XL analyzers. The order supports healthcare operations at VA medical facilities and has a completion date of July 31, 2024. Diasorin Inc. is the U.S. subsidiary of the parent company Diasorin S.P.A., which holds several significant indefinite delivery vehicles with the VA...
- Diasorin Inc. was awarded a $124,005 firm fixed price delivery order contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 to provide Diasorin reagents and Liaison XL analyzers. The contract has no set-aside designation and deliveries must be completed by September 30, 2020. The Veterans Health Administration oversees the vast majority of the healthcare services provided by the VA, including operating 1,255 health care facilities...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 (VA - VHA) awarded a $621,624.28 firm fixed price purchase order to Diasorin Inc. to provide chemiluminescence immunoassay testing services. The contract has a period of performance starting on March 10, 2022 through March 9, 2023 and will be performed in Long Beach, California. Diasorin Inc. will serve as the prime contractor to provide clinical diagnostic testing services to the VA through its proprietary chemiluminescence immunoassay platform and assays. No subcontractors were identified.
Generated 11/27/23, 5:38 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Supplemental Agreement for work within scope | ($39k) | 8/8/23 | |
| P00001 | Exercise an Option | $0 | 9/9/22 | |
| Not listed | Not listed | $661.0k | 3/10/22 |